Encompass Health Corp (NYSE: EHC) has reported E.P.S. of $1.13 for its first fiscal quarter (ending March 31) versus $0.89 for the same period a year ago. E.P.S. were $3.87 for the latest four quarters through March 31 versus $2.82 for the same period a year ago.
Recent Price Action
On 4/24/24, Encompass Health Corp (NYSE: EHC) stock rose modestly by 0.4%, closing at $82.80. Moreover, trading volume in this advance was unusually high at 176% of normal. Relative to the market the stock has been strong over the last nine months and has risen 3.5% during the last week.
Current PriceTarget Research Rating
EHC is expected to continue to be a major Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Encompass Health has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Encompass Health has a poor Appreciation Score of 16 but a good Power Rating of 73, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this new information and positive market action we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment